Atrial septal defect
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: prospective observational study Significant left-to-right shunt, right ventricular (RV) volume overload, and/or clinical symptoms of heart failure or paradoxical embolism Atomically feasible for percutaneous ASD closure
Exclusion criteria
Exclusion criteria: Eisenmenger physiology
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint is the composite events including cardiac death, heart failure during hospitalization, heart failure after discharge , adjunctive diuretics, de novo palpitation and stroke after ASD closure. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints New York Heart Assoission classification | — |
Countries
Japan
Contacts
Department of Internal Medicine, Kobe University Graduate School of Medicine Division of Cardiovascular Medicine